Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lock

Showing results (61-70 of 220) with videos related to

Pageof 22
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 18, 1994
Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunityA M Gautam, C B Lock, D E Smilek, et al.
The International Journal of Biochemistry & Cell Biology|December 28, 2007
Insight into the selectivity of arsenic trioxide for acute promyelocytic leukemia cells by characterizing Saccharomyces cerevisiae deletion strains that are sensitive or resistant to the metalloidPierre J Dilda, Gabriel G Perrone, Amanda Philp, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Interactions between antitumor drugs and radiation in mammalian tumor cell lines: differential drug responses and mechanisms of resistance following fractionated X-irradiation or continuous drug exposure in vitroB T Hill, R D Whelan, L K Hosking, et al.
British Journal of Haematology|February 21, 2025
Immune-deficient MISTRG mice support expansion of leukaemia-initiating cells in xenograft models of paediatric acute myeloid leukaemiaPatrick Connerty, Jinhan Xie, Fatima El-Najjar, et al.
Leukemia|June 22, 2001
High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistanceV S Catts, M L Farnsworth, M Haber, et al.
Proteomics|February 4, 2006
Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo studyNicole M Verrills, Natalia L Liem, Tracy Y E Liaw, et al.
Leukemia|May 5, 2026
A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemiaSara M A Mohamed, Peter Schofield, Kathryn Evans, et al.
Cancer Chemotherapy and Pharmacology|June 15, 1999
Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposideM J Elliott, K M Murphy, L Stribinskiene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer EffectsJeyran Shahbazi, Pei Y Liu, Bernard Atmadibrata, et al.
Blood|June 17, 1998
Blood coagulation in hemophilia A and hemophilia CK M Cawthern, C van 't Veer, J B Lock, et al.
Pageof 22

Showing results (61-70 of 220) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|January 18, 1994
Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunityA M Gautam, C B Lock, D E Smilek, et al.
The International Journal of Biochemistry & Cell Biology|December 28, 2007
Insight into the selectivity of arsenic trioxide for acute promyelocytic leukemia cells by characterizing Saccharomyces cerevisiae deletion strains that are sensitive or resistant to the metalloidPierre J Dilda, Gabriel G Perrone, Amanda Philp, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1988
Interactions between antitumor drugs and radiation in mammalian tumor cell lines: differential drug responses and mechanisms of resistance following fractionated X-irradiation or continuous drug exposure in vitroB T Hill, R D Whelan, L K Hosking, et al.
British Journal of Haematology|February 21, 2025
Immune-deficient MISTRG mice support expansion of leukaemia-initiating cells in xenograft models of paediatric acute myeloid leukaemiaPatrick Connerty, Jinhan Xie, Fatima El-Najjar, et al.
Leukemia|June 22, 2001
High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistanceV S Catts, M L Farnsworth, M Haber, et al.
Proteomics|February 4, 2006
Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo studyNicole M Verrills, Natalia L Liem, Tracy Y E Liaw, et al.
Leukemia|May 5, 2026
A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemiaSara M A Mohamed, Peter Schofield, Kathryn Evans, et al.
Cancer Chemotherapy and Pharmacology|June 15, 1999
Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposideM J Elliott, K M Murphy, L Stribinskiene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer EffectsJeyran Shahbazi, Pei Y Liu, Bernard Atmadibrata, et al.
Blood|June 17, 1998
Blood coagulation in hemophilia A and hemophilia CK M Cawthern, C van 't Veer, J B Lock, et al.
Pageof 22